erdafitinib
Balversa Approved for Locally Advanced or Metastatic Urothelial Carcinoma
The FDA approved erdafitinib (Balversa, Janssen Biotech) for adult patients with locally advanced or metastatic ...
JANUARY 22, 2024
Erdafitinib Shows Promise in Advanced Bladder Cancer
The fibroblast growth factor receptor inhibitor erdafitinib (Balversa, Janssen) showed promising antitumor activity ...
AUGUST 23, 2019
Load more